HomeNewsOpinionProviding development aid has been an important part of Indian foreign policy. Will it change due to COVID-19?

Providing development aid has been an important part of Indian foreign policy. Will it change due to COVID-19?

The COVID-19 situation may push India further to secure more assistance and soft loans under various bilateral or multilateral windows.

May 18, 2020 / 08:38 IST
Story continues below Advertisement

In the context of COVID-19, France has announced that it will provide €200 million to India to support vulnerable sections of the society. President Trump has said that the US will airlift 200 ventilators to India costing $2.6 million. Earlier, the US Centers for Disease Control and Prevention (CDC) agreed to provide $3.6 million to assist India's response to coronavirus. The World Bank’s total commitment to India’s COVID-19 response has reached $2 billion. To strengthen the Indian health system, the China-based Asian Infrastructure Investment Bank (AIIB) has approved a loan of $500 million.

For more than a decade, the narrative has been that as a rising power, India has become a major aid provider rather than a recipient of development aid. In fact, provision of development assistance abroad has become an important part of Indian foreign policy. Is it now changing because COVID-19? A careful analysis of development data reveals that the shift was already underway in the last few years, much before COVID-19 arrived on the scene.

Story continues below Advertisement

While answering a question in the Loka Sabha in March 2017, the Minister of State for External Affairs, General V K Singh asserted that “in the last three years, India has provided more aid to foreign countries than it has received”. The figures, provided were about grants-in-aid rather than soft loans. Still, from 2005 onwards, Indian development profile was moving more towards provider of development cooperation.

Indian development activities abroad broadly fall under three major headings. These include lines of credit (LOCs), capacity-building, particularly the Indian Technical and Economic Cooperation (ITEC) program, and bilateral grant assistance projects.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show